RNASEH2B loss and PARP inhibition in advanced prostate cancer.
Carmichael J, Figueiredo I, Gurel B, Beije N, Yuan W, Rekowski J, Seed G, Carreira S, Bertan C, Fenor de la Maza MLD, Chandran K, Neeb A, Welti J, Gallagher L, Bogdan D, Crespo M, Riisnaes R, Ferreira A, Miranda S, Lu J, Shen MM, Hall E, Porta N, Westaby D, Guo C, Grochot R, Lord CJ, Mateo J, Sharp A, de Bono J.
Carmichael J, et al. Among authors: miranda s.
J Clin Invest. 2024 Jun 4:e178278. doi: 10.1172/JCI178278. Online ahead of print.
J Clin Invest. 2024.
PMID: 38833311
Free article.